Autism spectrum disorder and particulate matter air pollution before, during, and after pregnancy: A nested case–control analysis within the nurses’ health study II cohort

Environmental Health Perspectives

Volumn 123, Issue 3, 2015, Pages 264-270

  Raz, Raanan ^a   Roberts, Andrea L ^a   Lyall, Kristen ^b,c   Hart, Jaime E ^a,d   Just, Allan C ^a   Laden, Francine ^a,b,d   Weisskopf, Marc G ^a,b  

^a Department of Environmental Health ^*  (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AIR POLLUTION; ARTICLE; AUTISM; CASE CONTROL STUDY; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MATERNAL SMOKING; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; UNITED STATES; AIR POLLUTANT; ANALYSIS; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; ENVIRONMENTAL MONITORING; PARTICULATE MATTER; PREGNANCY; PRENATAL EXPOSURE; PRESCHOOL CHILD; STATISTICS AND NUMERICAL DATA;

AIR POLLUTANT; PARTICULATE MATTER;

ADULT; AIR POLLUTANTS; AIR POLLUTION; CASE-CONTROL STUDIES; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; CHILD, PRESCHOOL; ENVIRONMENTAL MONITORING; FEMALE; HUMANS; MALE; MATERNAL EXPOSURE; PARTICULATE MATTER; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PROSPECTIVE STUDIES; SURVEYS AND QUESTIONNAIRES; UNITED STATES;

EID: 84925060943     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1408133     Document Type: Article

References (48)

1. Atladóttir HO, Thorsen P, Østergaard L, Schendel DE, Lemcke S, Abdallah M, et al. 2010. Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders. J Autism Dev Disord 40:1423–1430; doi:10.1007/s10803-010-1006-y.
2. Becerra TA, Wilhelm M, Olsen J, Cockburn M, Ritz B. 2013. Ambient Air Pollution and Autism in Los Angeles County, California. Environ Health Perspect 121:380–386; doi:10.1289/ehp.1205827.
3. Careaga M, Hansen RL, Hertz-Piccotto I, Van de Water J, Ashwood P. 2013. Increased anti-phospholipid antibodies in autism spectrum disorders. Mediators Inflamm 2013:935608; doi:10.1155/2013/935608.
4. Constantino JN, Davis SA, Todd RD, Schindler MK, Gross MM, Brophy SL, et al. 2003. Validation of a brief quantitative measure of autistic traits: compari son of the social responsiveness scale with the autism diagnostic interview-revised. J Autism Dev Disord 33:427–433.
5. Constantino JN, Przybeck T, Friesen D, Todd RD. 2000. Reciprocal social behavior in children with and without pervasive developmental disorders. J Dev Behav Pediatr 21:2–11.
6. Croen LA, Najjar DV, Ray GT, Lotspeich L, Bernal P. 2006. A comparison of health care utilization and costs of children with and without autism spectrum disorders in a large group-model health plan. Pediatrics 118:e1203–e1211; doi:10.1542/peds.2006-0127.
7. Crump KS, Kjellström T, Shipp AM, Silvers A, Stewart A. 1998. Influence of prenatal mercury exposure upon scholastic and psychological test performance: benchmark analysis of a New Zealand cohort. Risk Anal 18:701–713.
8. Depino AM. 2013. Peripheral and central infammation in autism spectrum disorders. Mol Cell Neurosci 53:69–76; doi:10.1016/j.mcn.2012.10.003.
9. Flanders WD, Klein M, Darrow LA, Strickland MJ, Sarnat SE, Sarnat JA, et al. 2011. A method for detection of residual confounding in time-series and other observational studies. Epidemiology 22:59–67; doi:10.1097/EDE.0b013e3181fdcabe.
10. French LR, Bertone A, Hyde KL, Fombonne E. 2013. Epidemiology of autism spectrum disorders. In: The Neuroscience of Autism Spectrum Disorders (Buxbaum JD, Hof PR, eds). New York:Academic Press, 3–24.
11. Gadad BS, Hewitson L, Young KA, German DC. 2013. Neuropathology and animal models of autism: genetic and environmental factors. Autism Res Treat 2013:731935; doi:10.1155/2013/731935.
12. Grandjean P, Landrigan PJ. 2006. Developmental neuro-toxicity of industrial chemicals. Lancet 368:2167–78; doi:10.1016/S0140-6736(06)69665-7.
13. Gray SC, Edwards SE, Miranda ML. 2013. Race, socio-economic status, and air pollution exposure in North Carolina. Env Res 126:152-8; doi:10.1016/j.envres.2013.06.005.
14. Grønborg TK, Schendel DE, Parner ET. 2013. Recurrence of autism spectrum disorders in full- and half-siblings and trends over time: a population-based cohort study. JAMA Pediatr 167:947–953; doi:10.1001/jamapediatrics.2013.2259.
15. Hallmayer J, Cleveland S, Torres A, Phillips J, Cohen B, Torigoe T, et al. 2011. Genetic heritability and shared environmental factors among twin pairs with autism. Arch Gen Psychiatry 68:1095–1102; doi:10.1001/archgenpsychiatry.2011.76.
16. Hertz-Picciotto I, Herr CEW, Yap PS, Dostál M, Shumway RH, Ashwood P, et al. 2005. Air pollution and lymphocyte phenotype proportions in cord blood. Environ Health Perspect 113:1391–1398; doi:10.1289/ehp.7610.
17. Hertz-Picciotto I, Park HY, Dostal M, Kocan A, Trnovec T, Sram R. 2008. Prenatal exposures to persistent and non-persistent organic compounds and effects on immune system development. Basic Clin Pharmacol Toxicol 102:146–154; doi:10.1111/j.1742-7843.2007.00190.x.
18. Kalkbrenner AE, Braun JM, Durkin MS, Maenner MJ, Cunniff C, Lee L, et al. 2012. Maternal smoking during pregnancy and the prevalence of autism spectrum disorders, using data from the autism and developmental disabilities monitoring network. Environ Health Perspect 120:1042–1048; doi:10.1289/ehp.1104556.
19. Leslie DL, Martin A. 2007. Health care expenditures associated with autism spectrum disorders. Arch Pediatr Adolesc Med 161:350–355; doi:10.1001/archpedi.161.4.350.
20. Li N, Sioutas C, Cho A, Schmitz D, Misra C, Sempf J, et al. 2003. Ultrafne particulate pollutants induce oxidative stress and mitochondrial damage. Environ Health Perspect 111:455–460; doi:10.1289/ehp.6000.
21. Libbey JE, Sweeten TL, McMahon WM, Fujinami RS. 2005. Autistic disorder and viral infections. J Neurovirol 11:1–10; doi:10.1080/13550280590900553.
22. Lipsitch M, Tchetgen Tchetgen E, Cohen T. 2010. Negative controls: a tool for detecting confounding and bias in observational studies. Epidemiology 21:383–8; doi:10.1097/EDE.0b013e3181d61eeb.
23. Lord C, Rutter M, Couteur A. 1994. Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord 24:659–685.
24. Lyall K, Pauls DL, Spiegelman D, Santangelo SL, Ascherio A. 2012. Fertility therapies, infertility and autism spectrum disorders in the Nurses’ Health Study II. Paediatr Perinat Epidemiol 26:361–372; doi:10.1111/j.1365-3016.2012.01294.x.
25. Mandell DS, Cao J, Ittenbach R, Pinto-Martin J. 2006. Medicaid expenditures for children with autistic spectrum disorders: 1994 to 1999. J Autism Dev Disord 36:475–485; doi:10.1007/s10803-006-0088-z.
26. McFadden K, Minshew NJ. 2013. Evidence for dysregu-lation of axonal growth and guidance in the etiology of ASD. Front Hum Neurosci 7:671; doi:10.3389/fnhum.2013.00671.
27. MohanKumar SMJ, Campbell A, Block M, Veronesi B. 2008. Particulate matter, oxidative stress and neuro-toxicity. Neurotoxicology 29:479–488; doi:10.1016/j.neuro.2007.12.004.
28. Napoli E, Wong S, Giulivi C. 2013. Evidence of reactive oxygen species-mediated damage to mitochondrial DNA in children with typical autism. Mol Autism 4:2; doi:10.1186/2040-2392-4-2.
29. Patterson PH. 2011. Maternal infection and immune involvement in autism. Trends Mol Med 17:389–394; doi:10.1016/j.molmed.2011.03.001.
30. Perera FP, Li Z, Whyatt R, Hoepner L, Wang S, Camann D, et al. 2009. Prenatal airborne polycyclic aromatic hydrocarbon exposure and child IQ at age 5 years. Pediatrics 124:e195–e202; doi:10.1542/peds.2008-3506.
31. Quaak I, Brouns M, Van de Bor M. 2013. The dynamics of autism spectrum disorders: how neurotoxic compounds and neurotransmitters interact. Int J Environ Res Public Health 10:3384–3408; doi:10.3390/ijerph10083384.
32. Raz R, Lerner-Geva L, Leon O, Chodick G, Gabis LV. 2013. A survey of out-of-pocket expenditures for children with autism spectrum disorder in Israel. J Autism Dev Disord 43(10):2295–2302; doi:10.1007/s10803-013-1782-2.
33. Rice D, Barone S Jr. 2000. Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environ Health Perspect 108:511–533.
34. Roberts AL, Kristen L, Hart JE, Laden F, Just AC, Bobb JF, et al. 2013. Perinatal air pollutant exposures and autism spectrum disorder in the children of Nurses’ Health Study II participants. Environ Health Perspect 121:978–984; doi:10.1289/ehp.1206187.
35. Rodier PM. 1995. Developing brain as a target of toxicity. Environ Health Perspect 103(suppl 6):73–76.
36. Shimabukuro TT, Grosse SD, Rice C. 2008. Medical expenditures for children with an autism spectrum disorder in a privately insured population. J Autism Dev Disord 38:546–552; doi:10.1007/s10803-007-0424-y.
37. Solomon CG, Willett WC, Carey VJ, Rich-Edwards J, Hunter DJ, Colditz GA, et al. 1997. A prospective study of pregravid determinants of gestational diabetes mellitus. JAMA 278:1078–1083.
38. Stillerman KP, Mattison DR, Giudice LC, Woodruff TJ. 2008. Environmental exposures and adverse pregnancy outcomes: a review of the science. Reprod Sci 15:631–650; doi:10.1177/1933719108322436.
39. Stoner R, Chow ML, Boyle MP, Sunkin SM, Mouton PR, Roy S, et al. 2014. Patches of disorganization in the neocortex of children with autism. N Engl J Med 370:1209–1219; doi:10.1056/NEJMoa1307491.
40. Su JG, Jerrett M, Beckerman B, Wilhelm M, Ghosh JK, Ritz B. 2009. Predicting traffc-related air pollution in Los Angeles using a distance decay regression selection strategy. Environ Res 109:657–670; doi:10.1016/j.envres.2009.06.001.
41. Suglia SF, Gryparis A, Wright RO, Schwartz J, Wright RJ. 2008. Association of black carbon with cognition among children in a prospective birth cohort study. Am J Epidemiol 167:280–286; doi:10.1093/aje/kwm308.
42. Voineagu I, Wang X, Johnston P, Lowe JK, Tian Y, Horvath S. 2011. Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature 474:380–384; doi:10.1038/nature10110.
43. Volk HE, Hertz-Picciotto I, Delwiche L, Lurmann F, McConnell R. 2011. Residential proximity to freeways and autism in the CHARGE study. Environ Health Perspect 119:873–877; doi:10.1289/ehp.1002835.
44. Volk HE, Lurmann F, Penfold B, Hertz-Piccotto I, McConnell R. 2013. Traffic-related air pollution, particulate matter, and autism. JAMA Psychiatry 70:71–77; doi:10.1001/jamapsychiatry.2013.266.
45. Windham GC, Zhang L, Gunier R, Croen LA, Grether JK. 2006. Autism spectrum disorders in relation to distribution of hazardous air pollutants in the San Francisco Bay Area. Environ Health Perspect 114:1438–1444; doi:10.1289/ehp.9120.
46. Yanosky JD, Paciorek CJ, Laden F, Hart JE, Puett RC, Liao D, et al. 2014. Spatio-temporal modeling of partic-ulate air pollution in the conterminous United States using geographic and meteorological predictors. Environ Health 13:63; doi:10.1186/1476-069X-13-63.
47. Yanosky JD, Paciorek CJ, Schwartz J, Laden F, Puett R, Suh HH. 2008. Spatio-temporal modeling of chronic PM10 exposure for the Nurses’ Health Study. Atmos Env (1994) 42:4047–4062; doi:10.1016/j.atmosenv.2008.01.044.
48. Yanosky JD, Paciorek CJ, Suh HH. 2009. Predicting chronic fine and coarse particulate exposures using spatiotemporal models for the Northeastern and Midwestern United States. Environ Health Perspect 117:522–529; doi:10.1289/ehp.11692.